The E2F transcription factor 1 transactives stathmin 1 in hepatocellular carcinoma. - Wikidata - wikimedia - TriplyDB

The E2F transcription factor 1 transactives stathmin 1 in hepatocellular carcinoma.

The E2F transcription factor 1 transactives stathmin 1 in hepatocellular carcinoma.

http://www.wikidata.org/entity/Q46825794

about

Stathmin-dependent molecular targeting therapy for malignant tumor: the latest 5 years' discoveries and developments Comprehensive analysis of microRNA-regulated protein interaction network reveals the tumor suppressive role of microRNA-149 in human hepatocellular carcinoma via targeting AKT-mTOR pathway.Genome-wide analysis of the oxyntic proliferative isthmus zone reveals ASPM as a possible gastric stem/progenitor cell marker over-expressed in cancer.The cAMP responsive element binding protein 1 transactivates epithelial membrane protein 2, a potential tumor suppressor in the urinary bladder urothelial carcinoma E2F transcription factors and digestive system malignancies: how much do we know?Thyroid hormone suppresses expression of stathmin and associated tumor growth in hepatocellular carcinoma An underlying prognosis predictor of hepatocellular carcinoma: Oncoprotein 18.Bortezomib effect on E2F and cyclin family members in human hepatocellular carcinoma cell lines.Transcription addiction: can we garner the Yin and Yang functions of E2F1 for cancer therapy?Activation of an AKT/FOXM1/STMN1 pathway drives resistance to tyrosine kinase inhibitors in lung cancer.The Spectrum of E2F in Liver Disease--Mediated Regulation in Biology and Cancer.E2F1: a promising regulator in ovarian carcinoma.SIAH ubiquitin ligases regulate breast cancer cell migration and invasion independent of the oxygen status.Overexpression of stathmin 1 confers an independent prognostic indicator in nasopharyngeal carcinoma.E2F transcription factors and digestive system malignancies: how much do we know?Functional characterization of E2F3b in human HepG2 liver cancer cell line.The effect of downregulation of Stathmin gene on biological behaviors of U373 and U87-MG glioblastoma cells.SET7/9 promotes hepatocellular carcinoma progression through regulation of E2F1

P2860

Q28079927-52E0C04B-ED25-4F9E-AF39-A8370B5208E9 Q34630091-BA1FD540-9772-47D6-83AC-87108E856C56 Q35692884-C61CDB06-7195-4BC0-B546-A659CB46A2C2 Q35832332-F074308E-2E45-4F17-A76C-CA96989E12FA Q36897885-1EC496D0-2E1C-40D6-BEF7-23FBE2262D77 Q37487309-107D8529-97C1-4F4B-B933-C3253630C879 Q37565193-A3364AC1-13AB-4D63-AC5A-C9A531C93369 Q37578604-8E0F8E99-1B53-4057-AE88-E550FCFA1899 Q38237693-417D6F99-9A2C-4302-807A-A7A5D5464903 Q38603815-E8D7DD18-E188-41B0-BD7C-69A8A43CFE5B Q38633009-7AFE6629-46A2-4D41-865D-7BC4BE971746 Q38691452-87FFAFB1-7DC2-4BAD-A8FA-5188FC29B669 Q38812815-865A9093-782A-41BF-983C-0728A49EEDD3 Q39064242-159AB650-0522-4479-8AEA-BED938A9CB7B Q42772377-A154C910-2A7D-4709-BA0B-5803F1D09011 Q47405744-0738657F-036C-469D-9CCD-CC5D379C13E1 Q55427270-552A08D9-B965-4A71-91E6-C25BCF12BC16 Q58802944-655ECE1F-4B40-46E3-A6A8-8EDB691E1C9C

P2860

The E2F transcription factor 1 transactives stathmin 1 in hepatocellular carcinoma.

http://www.wikidata.org/entity/Q46825794

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

2012年學術文章

@zh-hant

name

The E2F transcription factor 1 transactives stathmin 1 in hepatocellular carcinoma.

@en

The E2F transcription factor 1 transactives stathmin 1 in hepatocellular carcinoma.

@nl

type

label

The E2F transcription factor 1 transactives stathmin 1 in hepatocellular carcinoma.

@en

The E2F transcription factor 1 transactives stathmin 1 in hepatocellular carcinoma.

@nl

prefLabel

The E2F transcription factor 1 transactives stathmin 1 in hepatocellular carcinoma.

@en

The E2F transcription factor 1 transactives stathmin 1 in hepatocellular carcinoma.

@nl

P1433

Q46825794-14AFB510-12D2-4521-AFB0-00ECE95AB298

P1476

Q46825794-D96A22E2-397F-468C-8C0A-C980555EFA57

P2093

Q46825794-3534912C-E7FE-409D-9735-1BEA97AC69AC

Q46825794-3B227D8D-463C-4AFD-A286-7D515FA5BA66

Q46825794-4D9232F4-7B3F-4F44-8B43-D4E521F468A5

Q46825794-4DBA0C5D-589D-47F1-B54E-0CA6BE99565B

Q46825794-664E97AF-AD2C-443B-8B05-B3AC9813B295

Q46825794-6FE5464A-7D60-42B8-80A1-6FDA4986B57C

Q46825794-A739E5E4-8550-4BDD-B22C-B69AB8DA5EB8

Q46825794-C076AB1D-97B8-423F-B7A8-5E4EE3FD8F75

Q46825794-CB73C56C-94EE-4475-B1C0-60DCE6755262

Q46825794-FB498782-75DC-4D8E-9B77-E712B78DFE64

P2860

Q46825794-051FA05B-6D3D-4686-A1BC-A93C1619CAED

Q46825794-070C3D86-B8B1-452F-93EA-69781A4D2F81

Q46825794-0979F5EC-1470-457B-AA1B-BADF88C3DE2A

Q46825794-18879250-3B71-4382-890F-58B0DEB0B97C

Q46825794-18E37E8F-F416-4A1B-91D9-11F6F0F8B7C2

Q46825794-1A95A925-6401-421E-85D7-DE58F7992A19

Q46825794-1B7B3E80-CEBC-4616-B1FA-FDD96355479E

Q46825794-23F4B73B-B245-4A7A-96E7-CFDF676D9EBA

Q46825794-2449905D-41A6-46A2-A7B9-A8D26E01E4B8

Q46825794-2E67439B-91CE-46E3-A656-1F10CB5CE844

P2888

Q46825794-3BCA76C1-8971-4E2B-A51A-6A96F011878B

P304

Q46825794-D9C12630-D808-46F3-9093-CD7A23388E57

P31

Q46825794-D03A56BA-B05E-44A2-87F2-68837604E642

P356

Q46825794-96927884-1AF6-44E8-B846-B695BC643B3C

P433

Q46825794-D1F9FC40-7959-4324-8B86-CE34B1A0526D

P478

Q46825794-2A8DF101-B25E-4DEC-9CBF-06F1AFF001E6

P577

Q46825794-FB109BEA-AA98-4CE3-AEE7-3BA9A1B23F82

P6179

Q46825794-F5626B3B-D800-4BA9-A929-1D70A552D089

P698

Q46825794-DC5CC032-F42F-42C1-AA2F-C83A8A185B31

P356

S10434-012-2519-8

P1433

Annals of Surgical Oncology

P1476

The E2F transcription factor 1 transactives stathmin 1 in hepatocellular carcinoma.

@en

P2093

Chien-Feng Li

http://www.w3.org/2001/XMLSchema#string

Hong-Yu Tseng

http://www.w3.org/2001/XMLSchema#string

Hsuan-Ying Huang

http://www.w3.org/2001/XMLSchema#string

Kuo-Chan Horng

http://www.w3.org/2001/XMLSchema#string

Li-Ching Wu

http://www.w3.org/2001/XMLSchema#string

Lih-Ren Chen

http://www.w3.org/2001/XMLSchema#string

Wen-Ren Wu

http://www.w3.org/2001/XMLSchema#string

Yi-Ling Chen

http://www.w3.org/2001/XMLSchema#string

Yih-Huei Uen

http://www.w3.org/2001/XMLSchema#string

Yow-Ling Shiue

http://www.w3.org/2001/XMLSchema#string

P2860

Genomic targets of the human c-Myc protein

E2F integrates cell cycle progression with DNA repair, replication, and G(2)/M checkpoints

Differentially regulated genes as putative targets of amplifications at 20q in ovarian cancers

Stathmin regulates centrosomal nucleation of microtubules and tubulin dimer/polymer partitioning.

Identification of novel nasopharyngeal carcinoma biomarkers by laser capture microdissection and proteomic analysis.

Stathmin, a new target of PRL-3 identified by proteomic methods, plays a key role in progression and metastasis of colorectal cancer.

Overexpression of stathmin1 in the diffuse type of gastric cancer and its roles in proliferation and migration of gastric cancer cells.

Gene expression patterns in human liver cancers.

Risk of HCC: genetic heterogeneity and complex genetics.

Stathmin 1, a marker of PI3K pathway activation and regulator of microtubule dynamics, is expressed in early pelvic serous carcinomas.

P2888

s10434-012-2519-8

P304

4041-4054

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1245/S10434-012-2519-8

http://www.w3.org/2001/XMLSchema#string

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

20

http://www.w3.org/2001/XMLSchema#string

P577

2012-08-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1021826062

http://www.w3.org/2001/XMLSchema#string

P698

22911364

http://www.w3.org/2001/XMLSchema#string